9）Godoy AT, Eberlin MN, Simionato AVC. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers. Talanta 2020; 210: 120640.10）Jinno D, Kanemitsu Y, Saitoh K, Nankumo S, Tsukamoto H, Matsumoto Y, et al. Rapid and selective simultaneous quantitative analysis of modified nucleosides using multi-column liquid chromatography-tandem mass spectrometry. J Anal Sci Technol 2017; 8(1): 1.11）Witjes BC, Ahsman MJ, van der Nagel BC, Tibboel D, Mathot RA. Simultaneous assay of sildenafil and desmethylsildenafil in neonatal plasma by ultra-performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 2010; 24(2): 180-5.12）Esaki H, Aoki F, Maegawa T, Hirota K, Sajiki H. Synthesis of base-selectively deuterium-labelled nucleosides by the Pd/C-catalyzed H-D exchange reaction in deuterium oxide. Heterocycles 2005; 66(1): 361-9.13）Okamura K, Takayama K, Izumi M, Harada T, Furuyama K, Nakanishi Y. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. Lung Cancer 2013; 80(1): 45-9.14）Zhao W, Yu H, Han Z, Gao N, Xue J, Wang Y. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer. Int J Clin Exp Pathol 2015; 8(8): 9506-11.301）Nakano K, Nakao T, Schram KH, Hammargren WM, McClure TD, Katz M, et al. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Clin Chim Acta 1993; 218(2): 169-83.2）Ian AR, Molly EE, Tao P, Chuan H. Dynamic RNA modifications in gene expression regulation. Cell 2017; 169(7): 1187-200.3）Mishima E, Inoue C, Saigusa D, Inoue R, Ito K, Suzuki Y, et al. Conformational change in transfer RNA is an early indicator of acute cellular damage. J Am Soc Nephrol 2014; 25(10): 2316-26.4）Hsu WY, Lin WD, Tsai Y, Lin CT, Wang HC, Jeng LB, et al. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta 2011; 412(19–20): 1861-6.5）Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, et al. Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension. Circulation 2017; 135(5): 460-75.6）Cho SH, Choi MH, Lee WY, Chung BC. Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal. Clin Biochem 2009; 42(6): 540-3.7）Djukovic D, Baniasadi HR, Kc R, Hammoud Z, Raftery D. Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma. Rapid Commun Mass Spectrom 2010; 24(20): 3057-62.8）Rodríguez-Gonzalo E, Herrero-Herrero L, García-Gómez D. Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2016; 1019: 132-9.文 献
元のページ ../index.html#44